Founder & Editor
Alex Price is the founder & editor of Undiluted. Having previously built and sold an agency and media business to a debt financed roll up, he launched Undiluted in 2026. Alex talks with funds, banks, advisors and others across the growth lending ecosystem daily.
LinkedIn (opens in a new tab)Hercules Capital has provided 4D Molecular Therapeutics with a senior secured credit facility of up to $200 million. 4DMT drew $20 million at closing.
2 min read29 Jun 2026Hercules Capital has expanded its senior secured term loan facility with Dyne Therapeutics to $400 million. Dyne drew $50 million at this close. It has now borrowed $200 million, with $200 million still available.
2 min read17 Jun 2026The New York company makes kitchen-management software and will use the facility for European expansion, after a $24 million Series A in August 2022.
2 min read13 Jun 2026Liquidity has provided NALA with a credit facility of up to $50 million through Mars Growth Capital, a joint venture between Liquidity and MUFG Bank.
2 min read28 May 2026The New York fertility company matches patients with clinics and underwrites outcome-based financing. It will use the facility to scale in the United States, after a $14 million Series A in January 2025.
2 min read20 May 2026The asset-based facility will support growth in prime services and margin financing at the multi-asset prime brokerage formed after Ripple bought Hidden Road.
2 min read11 May 2026Hercules Capital has provided Lexicon Pharmaceuticals with a loan facility of up to $100 million. The first $55 million was funded at closing to repay an existing loan with Oxford Finance.
2 min read4 May 2026Trinity Capital has committed up to $35 million of equipment financing to Torus, the Salt Lake City energy technology company. The Phoenix lender announced the facility on 30 April 2026.
2 min read30 Apr 2026Trinity Capital has committed a $30 million growth facility to Iantrek, the White Plains, New York medical technology company.
2 min read28 Apr 2026Trinity Capital has committed $50 million of growth capital to Cala Health, the San Mateo bioelectronic medicine company.
2 min read20 Apr 2026